Monogram Biosciences
From Wikipedia, the free encyclopedia
This article may not meet the notability guidelines for companies and organizations. If you are familiar with the subject matter, please expand or rewrite the article to establish its notability. The best way to address this concern is to reference published, third-party sources about the subject. If notability cannot be established, the article is more likely to be considered for redirection, merge or ultimately deletion, per Wikipedia:Guide to deletion. This article has been tagged since January 2008. |
The creator of this article, or someone who has substantially contributed to it, may have a conflict of interest regarding its subject matter. |
This article does not cite any references or sources. (January 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. |
Monogram Biosciences, Inc. | |
---|---|
Type | Public (NASDAQ: MGRM) |
Founded | {{{foundation}}} |
Headquarters | South San Francisco, California |
Key people | William D. Young, CEO, Chairman of the Board |
Industry | Biotechnology |
Products | PhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag |
Employees | 348 (2007) |
Website | http://www.monogrambio.com/ |
Monogram Biosciences Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
[edit] External links
- Official website
- Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression [1]
- Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay [2]
- Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development [3]
- Trofile Bests SensiTrop as Most Reliable Tropism Test [4]
- Monogram Biosciences teams up with Pfizer for HIV treatment [5]
- Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6]
- 2007 HIV Treatment Guidelines [7]
- All About HIV Tropism [8]